Clin Exp Otorhinolaryngol.  2021 Nov;14(4):427-430. 10.21053/ceo.2020.02215.

Prevalence of Olfactory or Gustatory Dysfunction in COVID-19 Patients: An Analysis Based on Korean Nationwide Claims Data

• Ahn EJ
• Min HJ

• KMID: 2522435
• DOI: http://doi.org/10.21053/ceo.2020.02215

Reference

1. Bousquet J, Akdis C, Jutel M, Bachert C, Klimek L, Agache I, et al. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: an ARIA-EAACI statement. Allergy. 2020; Mar. 31. [Epub]. https://doi.org/10.1111/all.14302.

2. Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, et al. Sudden and complete olfactory loss of function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020; Jul. 146(7):674–5.

3. Lechien JR, Cabaraux P, Chiesa-Estomba CM, Khalife M, Hans S, Calvo-Henriquez C, et al. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck. 2020; July. 42(7):1583–90.

4. Park YJ, Kim JM, Lee BR, Kim TH, Lee EG. Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015. Epidemiol Infect. 2018; Jan. 146(2):177–86.

5. Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020; Aug. 56(2):106024.

6. Sanli DE, Altundag A, Kandemirli SG, Yildirim D, Sanli AN, Saatci O, et al. Relationship between disease severity and serum IL-6 levels in COVID-19 anosmia. Am J Otolaryngol. 2021; Jan-Feb. 42(1):102796.

7. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020; Jul. 163(1):3–11.